NCT01494077

Brief Summary

The purpose of this research project is to determine if pancreatic cyst fluid can be diluted and provide an accurate Carcinoembryonic Antigen (CEA) level. The investigators hypothesis is that pancreatic cyst fluid obtained by EUS-FNA can be diluted effectively and accurately for the measurement of CEA levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2011

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 16, 2011

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

December 12, 2014

Status Verified

December 1, 2014

Enrollment Period

1.3 years

First QC Date

December 2, 2011

Last Update Submit

December 10, 2014

Conditions

Keywords

Pancreatic Cyst FluidDilutionCarcinoembryonic Antigen (CEA)

Outcome Measures

Primary Outcomes (1)

  • Accuracy of diluted CEA level

    The primary aim of this study is to determine if pancreatic cyst fluid can be diluted and provide an accurate CEA level.

    Pancreatic fluid is aspirated once during the procedure.

Study Arms (1)

EUS-FNA of Pancreatic Cyst

Patients who have a pancreatic cyst requiring standard of care EUS-FNA that yields 2.25 ML (or greater) of fluid will be included in the study.

Other: Laboratory processing for results

Interventions

There is no intervention. Extra fluid that is normally discarded will be processed.

EUS-FNA of Pancreatic Cyst

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are already scheduled for EUS-FNA of a pancreatic cyst at the H.H. Chao Comprehensive Digestive Disease Center at UC Irvine Medical Center. The procedure will be performed as usual per standard of care protocol with EUS-FNA of the cyst. Once the fluid is aspirated, it will be measured and if the fluid volume is 2.25 mL or greater than the patient will be included in the study.

You may qualify if:

  • Patients scheduled for EUS-FNA of a pancreatic cyst
  • Cyst must yield 2.25ml (or greater) of fluid

You may not qualify if:

  • Cysts yielding less than 2.25ml of fluid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

H. H. Chao Comprehensive Digestive Disease Center

Orange, California, 92868, United States

Location

MeSH Terms

Conditions

Pancreatic Cyst

Condition Hierarchy (Ancestors)

CystsNeoplasmsPancreatic DiseasesDigestive System Diseases

Study Officials

  • Kenneth J. Chang, MD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Medicine

Study Record Dates

First Submitted

December 2, 2011

First Posted

December 16, 2011

Study Start

April 1, 2011

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

December 12, 2014

Record last verified: 2014-12

Locations